Diagnosis and Management of Peritoneal Metastases from Ovarian Cancer

被引：76
作者：
Halkia, Evgenia [2 ]
Spiliotis, John [3 ]
Sugarbaker, Paul [1 ]
机构：
[1] Washington Canc Inst, Program Peritoneal Surface Malignancy, Washington, DC 20010 USA
[2] Metaxa Canc Mem Hosp, Dept Gynecol, Piraeus 18537, Greece
[3] Metaxa Canc Mem Hosp, Dept Surg Oncol 1, Piraeus 18537, Greece
来源：
GASTROENTEROLOGY RESEARCH AND PRACTICE | 2012年 / 2012卷
关键词：
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; RECURRENT EPITHELIAL OVARIAN; SECONDARY CYTOREDUCTIVE SURGERY; PHASE-III TRIAL; NEOADJUVANT CHEMOTHERAPY; EXPLORATORY ANALYSIS; COMPUTED-TOMOGRAPHY; CARCINOMATOSIS; PACLITAXEL; TUMOR;
D O I：
10.1155/2012/541842
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The management and the outcome of peritoneal metastases or recurrence from epithelial ovarian cancer are presented. The biology and the diagnostic tools of EOC peritoneal metastasis with a comprehensive approach and the most recent literatures data are discussed. The definition and the role of surgery and chemotherapy are presented in order to focuse on the controversial points. Finally, the paper discusses the new data about the introduction of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced epithelial ovarian cancer.
引用
收藏
页数：12
相关论文
共 108 条
[1]   Use of a symptom index, CA125 and HE4 to predict ovarian cancer [J].
Goff, B. ;
Andersen, M. ;
Lowe, K. ;
Scholler, N. ;
Bergan, L. ;
Drescher, C. ;
Paley, P. ;
Urban, N. .
GYNECOLOGIC ONCOLOGY, 2010, 116 (03) :S103-S103
[2]  
[Anonymous], 2009, INT J GYNECOL OBSTET, V105, P3
[3]  
[Anonymous], 2003, WHO CLASSIFICATION T
[4]  
[Anonymous], REG CANC TREAT
[5]  
[Anonymous], COCHRANE DATABASE SY
[6]  
[Anonymous], 2010, Cancer facts and figures
[7]  
[Anonymous], AJCC CANC STAGING HD
[8]   Intraperitoneal cisplatin and paclitaxel in ovarian cancer [J].
Armstrong, DK ;
Bundy, B ;
Wenzel, L ;
Huang, HQ ;
Baergen, R ;
Lele, S ;
Copeland, LJ ;
Walker, JL ;
Burger, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01) :34-43
[9]   Treatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery [J].
Bae, Jeong Hoon ;
Lee, Joon Mo ;
Ryu, Ki Sung ;
Lee, Yong Seok ;
Park, Yong Gyu ;
Hur, Soo Young ;
Ahn, Woong Shik ;
Namkoong, Seong Eun .
GYNECOLOGIC ONCOLOGY, 2007, 106 (01) :193-200
[10]   Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: A Gynecologic Oncology Group study [J].
Behbakht, Kian ;
Sill, Michael W. ;
Darcy, Kathleen M. ;
Rubin, Stephen C. ;
Mannel, Robert S. ;
Waggoner, Steven ;
Schilder, Russell J. ;
Cai, Kathy Q. ;
Godwin, Andrew K. ;
Alpaugh, R. Katherine .
GYNECOLOGIC ONCOLOGY, 2011, 123 (01) :19-26
12345678910